ARCHITECT I2000SR ANALYZER 03M74-02

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional report with the FDA on 2017-02-02 for ARCHITECT I2000SR ANALYZER 03M74-02 manufactured by Abbott Manufacturing Inc.

Event Text Entries

[66476194] An evaluation is in process. A followup report will be submitted when the evaluation is complete.
Patient Sequence No: 1, Text Type: N, H10


[66476195] The account generated (b)(6) architect (b)(6) results on a patient processed on the architect i2000sr. Initially, the patient tested architect (b)(6) (1. 06 index) but repeated (b)(6) (0. 7 index) with a new sample. The new sample was repeated several days later with (b)(6) results (1. 0 index). The patient is (b)(6) with high avidity. No impact to patient management was reported.
Patient Sequence No: 1, Text Type: D, B5


[74720924] A field service engineer (fse) replaced the valve, manifold kit for leaking and the valve, syringe for clogged/obstructed to resolve the issue. However; the fse considered the likely cause of the discrepant result issue to be the valve, syringe. A review of the architect i2000sr serial (b)(4) service history verified no reports of discrepant results since the part was replaced. The architect system operations manual provides information for the troubleshooting and maintenance concerning erratic results, including, but not limited to, the troubleshooting performed by the fse. The architect cmv igm package insert provides information regarding sample handling, result interpretation, and performance characteristics. A review of the architect i2000sr tracking and trending data in the revealed no systemic issues or adverse trends associated with the erratic result issue described in this complaint. The architect i2000sr erratic result rate is within acceptable limits with no trends identified. Also, a review for similar complaints identified no adverse trends of the valve, syringe. Use error may have contributed to the customer's issue as the first sample was hemolyzed and the fse replaced the valve, syringe, as well as the valve, manifold kit. No product deficiency or systemic issue was identified for the architect i2000sr and valve, syringe.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1628664-2017-00023
MDR Report Key6298609
Report SourceFOREIGN,HEALTH PROFESSIONAL
Date Received2017-02-02
Date of Report2017-04-24
Date of Event2016-12-24
Date Mfgr Received2017-03-29
Date Added to Maude2017-02-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag0
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNOEMI ROMERO-KONDOS, RN BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone224667-512
Manufacturer G1ABBOTT MANUFACTURING INC
Manufacturer Street1921 HURD DRIVE
Manufacturer CityIRVING TX 75038
Manufacturer CountryUS
Manufacturer Postal Code75038
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Sequence Number: 0

Brand NameARCHITECT I2000SR ANALYZER
Generic NameAUTOMATED IMMUNOASSAY ANALYZER
Product CodeLKQ
Date Received2017-02-02
Catalog Number03M74-02
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No0
Device Event Key0
ManufacturerABBOTT MANUFACTURING INC
Manufacturer Address1921 HURD DRIVE IRVING TX 75038 US 75038

Device Sequence Number: 1

Brand NameARCHITECT I2000SR ANALYZER
Generic NameAUTOMATED IMMUNOASSAY ANALYZER
Product CodeJJE
Date Received2017-02-02
Catalog Number03M74-02
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MANUFACTURING INC
Manufacturer Address1921 HURD DRIVE IRVING TX 75038 US 75038


Patients

Patient NumberTreatmentOutcomeDate
10 2017-02-02

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.